F. Reed Johnson | Scholars@Duke

F. Reed Johnson
Professor in Population Health Sciences

F. Reed Johnson, PhD, has more than 40 years of academic and research experience in health and environmental economics. He has served on the faculties of several universities in the United States, Canada, and Sweden, and as Distinguished Fellow at Research Triangle Institute. He currently is Senior Research Scholar in the Duke Clinical Research Institute. As a staff member in the US Environmental Protection Agency’s environmental economics research program during the 1980s, Reed helped pioneer the development of basic non-market valuation techniques which are widely used for benefit-cost analysis in health and environmental economics. He has designed and analyzed numerous surveys for measuring preferences for and value of health outcomes, health risk reductions, and improved environmental quality.

Dr. Johnson has over 140 publications in books and peer-reviewed journals. His research has been published in various medical journals, the Review of Economics and Statistics, Journal of Health Economics, Medical Decision Making, Health Economics, Value in Health, Journal of Policy Analysis and Management, and other journals. He has coauthored a book on techniques for using existing environmental and health value estimates for policy analysis.

His current research involves quantifying patients’ willingness to accept sideeffect risks in return for therapeutic benefits and estimating general time equivalences among health states. He led the first FDA sponsored study on patients’ willingness to accept benefit-risk tradeoffs for new health technologies. The study was used to develop recent FDA guidance on submitting patient-preference data to support regulatory reviews of medical devices.

Areas of expertise: Clinical Decision Sciences, Health Measurement, Health Policy, and Health Economics

Current Research Interests

Medical decision making
Quantitative patient-preference information
Quantitative patient and physician risk tolerance for medical interventions

Current Appointments & Affiliations

Professor in Population Health Sciences, Population Health Sciences, Basic Science Departments 2021
Member of the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 2015
Affiliate Faculty Member, Duke-Margolis Center for Health Policy, Duke - Margolis Center For Health Policy, Initiatives 2019

Contact Information

reed.johnson@duke.edu

Background
Education, Training, & Certifications
- Ph.D., State University of New York, Stony Brook 1974
Previous Appointments & Affiliations
- Professor in Population Health Sciences, Population Health Sciences, Basic Science Departments 2017 - 2020
- Professor in Medicine, Medicine, General Internal Medicine, Medicine 2016 - 2017
- Instructor, Temporary in the Department of Medicine, Medicine, General Internal Medicine, Medicine 2015 - 2016
Academic Positions Outside Duke
- Adjunct Professor of Public Policy, University of North Carolina, Chapel Hill. 2001 - 2010
- Fellow, Senior Fellow, Distinguished Fellow and Principal Economist, Research Triangle Institute. 2001 - 2014
- Visiting Professor of Economics, University of Stockholm, Sweden. 1984 - 1985
- Assistant, Associate, and Full Professor of Economics, U.S. Naval Academy, Annapolis. 1977 - 1992
- Visiting Assistant Professor of Economics, Simon Fraser University, British Columbia. 1976 - 1977
- Assistant Professor of Economics, Illinois State University. 1974 - 1976
Recognition
Awards & Honors
Research
Selected Grants
- Benefit Risk Tradeoffs Associated with PRO for PAD - Option Period awarded by Food and Drug Administration 2022 - 2024
- Benefit Risk Tradeoffs Associated with PRO for PAD awarded by Food and Drug Administration 2020 - 2024
- Patient Preference Study awarded by Janssen Research & Development, LLC 2022 - 2023
- Major Depression with Suicidal Ideation awarded by Janssen Scientific Affairs, LLC. 2020 - 2023
- Rescuing Kidneys at Risk of Discard awarded by Northwestern University 2019 - 2023
- Eosinophilic Esophagitis (EoE) awarded by Takeda Pharmaceutical Company Limited 2020 - 2022
- Patient Preferences in the Treatment of Diffuse Large B-cell Lymphoma awarded by MorphoSys US Inc. 2020 - 2021
- Treatment Switching Behavior among Multiple Myeloma Patients awarded by Amgen, Inc. 2018 - 2021
- Patient Preference Information: Bridging Regulatory Decisions and Clinical Practice awarded by Food and Drug Administration 2018 - 2021
- Preference Tx for Sequencing in NSCLC awarded by AstraZeneca Pharmaceuticals, LP 2018 - 2021
- Stated Therapy Preferences of Child Caregivers and Adult Patients with Peanut Allergy awarded by Aimmune Therapeutics 2018 - 2020
- Immunoglobulin Therapies Based on Treatment Experience awarded by Grifols USA, LLC 2017 - 2020
- Cancer Tx with a PARP Inhibitor VS Standard awarded by TESARO 2017 - 2020
- Stated-Preferences in Knee Arthroplasty awarded by Zimmer, Inc. 2016 - 2020
- Quatifying Patient Preferences for Heart Failure Interventions awarded by Medical Device Innovation Consortium 2019 - 2020
- Meningitis B Vaccine European study awarded by Pfizer, Inc. 2018 - 2020
- Women with BRCA-mutated Advanced Stage Ovarian Cancer awarded by AstraZeneca LP 2017 - 2019
- Pediatric Crohn's Disease Patient and Provider Risk-Benefit Preferences for Monotherapy versus Combination Therapy awarded by University of Pennsylvania 2015 - 2018
- Tissue and Data Acquisition Activity for the Study of Gynecologic Disease awarded by Henry M. Jackson Foundation 2016 - 2017
- Janssen TIDM Diabetes Study awarded by Janssen Research & Development, LLC 2015 - 2016
External Relationships
- International Society for Pharmacoeconomics and Outcomes Research
- Pfizer Inc.
- Sarepta Therapeutics, Inc.
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Johnson, F Reed. “Comment on: Taking the Shortcut: Simplifying Heuristics in Discrete Choice Experiments.” Patient, May 26, 2023. https://doi.org/10.1007/s40271-023-00629-8.
    Full Text Link to Item
  - Johnson, F Reed, Juan Marcos Gonzalez, John J. Sheehan, and Shelby D. Reed. “How Much Better is Faster? Value Adjustments for Health-Improvement Sequences.” Pharmacoeconomics, May 3, 2023. https://doi.org/10.1007/s40273-023-01266-7.
    Full Text Link to Item
  - Johnson, F Reed, Angelyn Fairchild, Dale Whittington, Amit K. Srivastava, Juan Marcos Gonzalez, and Liping Huang. “How Does the Public Evaluate Vaccines for Low-Incidence, Severe-Outcome Diseases? A General-Population Choice Experiment.” Patient 16, no. 2 (March 2023): 139–51. https://doi.org/10.1007/s40271-022-00602-x.
    Full Text Link to Item
  - Gonzalez Sepulveda, Juan Marcos, F Reed Johnson, Shelby D. Reed, Charles Muiruri, Carolyn A. Hutyra, and Richard C. Mather. “Patient-Preference Diagnostics: Adapting Stated-Preference Methods to Inform Effective Shared Decision Making.” Med Decis Making 43, no. 2 (February 2023): 214–26. https://doi.org/10.1177/0272989X221115058.
    Full Text Open Access Copy Link to Item
  - Kushner, Tatyana, Angelyn Fairchild, F Reed Johnson, Bruce E. Sands, Uma Mahadevan, Sreedhar Subramanian, Ashwin Ananthakrishnan, Christina Ha, and Meenakshi Bewtra. “Women's Willingness to Accept Risks of Medication for Inflammatory Bowel Disease During Pregnancy.” The Patient 15, no. 3 (May 2022): 353–65. https://doi.org/10.1007/s40271-021-00561-9.
    Full Text
  - Sepulveda, Juan Marcos Gonzalez, Drishti Baid, F Reed Johnson, and Eric A. Finkelstein. “What is a Good Death? A Choice Experiment on Care Indicators for Patients at End of Life.” J Pain Symptom Manage 63, no. 4 (April 2022): 457–67. https://doi.org/10.1016/j.jpainsymman.2021.11.005.
    Full Text Link to Item
  - Sinha, Saurabh R., Jui-Chen Yang, Matthew J. Wallace, Kiran Grover, F Reed Johnson, and Shelby D. Reed. “Patient preferences pertaining to treatment options for drug-resistant focal epilepsy.” Epilepsy Behav 127 (February 2022): 108529. https://doi.org/10.1016/j.yebeh.2021.108529.
    Full Text Link to Item
  - Reed, Shelby D., Jui-Chen Yang, Timothy Rickert, F Reed Johnson, Juan Marcos Gonzalez, Robert J. Mentz, Mitchell W. Krucoff, et al. “Quantifying Benefit-Risk Preferences for Heart Failure Devices: A Stated-Preference Study.” Circ Heart Fail 15, no. 1 (January 2022): e008797. https://doi.org/10.1161/CIRCHEARTFAILURE.121.008797.
    Full Text Link to Item
  - Gonzalez Sepulveda, Juan M., F Reed Johnson, and Deborah A. Marshall. “Incomplete information and irrelevant attributes in stated-preference values for health interventions.” Health Econ 30, no. 11 (November 2021): 2637–48. https://doi.org/10.1002/hec.4406.
    Full Text Link to Item
  - Gonzalez, J. M., S. D. Reed, and F. R. Johnson. “Stratified psoriasis treatment plans: why is patient preference information needed?” Br J Dermatol 185, no. 5 (November 2021): 882–83. https://doi.org/10.1111/bjd.20697.
    Full Text Link to Item
  - Reed, Shelby D., Jui-Chen Yang, Juan Marcos Gonzalez, and F Reed Johnson. “Quantifying Value of Hope.” Value Health 24, no. 10 (October 2021): 1511–19. https://doi.org/10.1016/j.jval.2021.04.1284.
    Full Text Link to Item
  - Hung, Anna, Juan Marcos Gonzalez, Jui-Chen Yang, Steve Hass, Edwin Kim, and F Reed Johnson. “Heterogeneity in Parent Preferences for Peanut Desensitization Therapy.” J Allergy Clin Immunol Pract 9, no. 9 (September 2021): 3459–65. https://doi.org/10.1016/j.jaip.2021.04.058.
    Full Text Link to Item
  - Johnson, F Reed, Juan Marcos Gonzalez, Jui-Chen Yang, Semra Ozdemir, and Steven Kymes. “Who Would Pay Higher Taxes for Better Mental Health? Results of a Large-Sample National Choice Experiment.” Milbank Q 99, no. 3 (September 2021): 771–93. https://doi.org/10.1111/1468-0009.12523.
    Full Text Link to Item
  - Havrilesky, Laura J., Amelia L. Scott, Brittany A. Davidson, Angeles Alvarez Secord, Jui-Chen Yang, F Reed Johnson, Juan Marcos Gonzalez, and Shelby D. Reed. “The preferences of women with ovarian cancer for oral versus intravenous recurrence regimens.” Gynecol Oncol 162, no. 2 (August 2021): 440–46. https://doi.org/10.1016/j.ygyno.2021.05.022.
    Full Text Link to Item
  - Yang, Jui-Chen, Shelby D. Reed, Steve Hass, Mark B. Skeen, and F Reed Johnson. “Is Easier Better Than Harder? An Experiment on Choice Experiments for Benefit-Risk Tradeoff Preferences.” Med Decis Making 41, no. 2 (February 2021): 222–32. https://doi.org/10.1177/0272989X20979833.
    Full Text Link to Item
  - Hutyra, Carolyn A., Juan Marcos Gonzalez, Jui-Chen Yang, F Reed Johnson, Shelby D. Reed, Annunziato Amendola, Michael P. Bolognesi, et al. “Patient Preferences for Surgical Treatment of Knee Osteoarthritis: A Discrete-Choice Experiment Evaluating Total and Unicompartmental Knee Arthroplasty.” J Bone Joint Surg Am 102, no. 23 (December 2, 2020): 2022–31. https://doi.org/10.2106/JBJS.20.00132.
    Full Text Link to Item
  - Reed, Shelby, Juan Marcos Gonzalez, and F Reed Johnson. “Willingness to Accept Trade-Offs Among COVID-19 Cases, Social-Distancing Restrictions, and Economic Impact: A Nationwide US Study.” Value Health 23, no. 11 (November 2020): 1438–43. https://doi.org/10.1016/j.jval.2020.07.003.
    Full Text Link to Item
  - Fairchild, A. O., E. G. Katz, S. D. Reed, F. R. Johnson, A. DiBernardo, D. Hough, J. Sing, and B. Levitan. “Patient preferences for ketamine-based antidepressant treatments in treatment-resistant depression: Results from a clinical trial and panel.” Neurology Psychiatry and Brain Research 37 (September 1, 2020): 67–78. https://doi.org/10.1016/j.npbr.2020.05.003.
    Full Text
  - Malone, Daniel C., Scott D. Ramsey, Donald L. Patrick, F Reed Johnson, C Daniel Mullins, Mark S. Roberts, Richard J. Willke, and Deborah A. Marshall. “Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report.” Value Health 23, no. 4 (April 2020): 409–15. https://doi.org/10.1016/j.jval.2020.03.001.
    Full Text Link to Item
  - Havrilesky, Laura J., Stephanie Lim, Jessie A. Ehrisman, Amelia Lorenzo, Angeles Alvarez Secord, Jui-Chen Yang, F Reed Johnson, Juan Marcos Gonzalez, and Shelby D. Reed. “Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatment.” Gynecol Oncol 156, no. 3 (March 2020): 561–67. https://doi.org/10.1016/j.ygyno.2020.01.026.
    Full Text Link to Item
  - Bewtra, Meenakshi, Shelby D. Reed, F Reed Johnson, Frank I. Scott, Erin Gilroy, Robert S. Sandler, Wenli Chen, and James D. Lewis. “Variation Among Patients With Crohn's Disease in Benefit vs Risk Preferences and Remission Time Equivalents.” Clin Gastroenterol Hepatol 18, no. 2 (February 2020): 406-414.e7. https://doi.org/10.1016/j.cgh.2019.05.010.
    Full Text Open Access Copy Link to Item
  - Reed, Shelby D., Angelyn O. Fairchild, F Reed Johnson, Juan Marcos Gonzalez, Robert J. Mentz, Mitchell W. Krucoff, and Sreekanth Vemulapalli. “Patients' Willingness to Accept Mitral Valve Procedure-Associated Risks Varies Across Severity of Heart Failure Symptoms.” Circ Cardiovasc Interv 12, no. 12 (December 2019): e008051. https://doi.org/10.1161/CIRCINTERVENTIONS.119.008051.
    Full Text Link to Item
  - Johnson, F Reed, Rachael L. DiSantostefano, Jui-Chen Yang, Shelby D. Reed, Johannes Streffer, and Bennett Levitan. “Something Is Better Than Nothing: The Value of Active Intervention in Stated Preferences for Treatments to Delay Onset of Alzheimer's Disease Symptoms.” Value Health 22, no. 9 (September 2019): 1063–69. https://doi.org/10.1016/j.jval.2019.03.022.
    Full Text Link to Item
  - Johnson, F Reed, Frank I. Scott, Shelby D. Reed, James D. Lewis, and Meenakshi Bewtra. “Comparing the Noncomparable: The Need for Equivalence Measures That Make Sense in Health-Economic Evaluations.” Value Health 22, no. 6 (June 2019): 684–92. https://doi.org/10.1016/j.jval.2019.03.011.
    Full Text Link to Item
  - Reed, Shelby D., Robert W. Dubois, F Reed Johnson, J Jaime Caro, and Charles E. Phelps. “Novel Approaches to Value Assessment Beyond the Cost-Effectiveness Framework.” Value Health 22, no. 6S (June 2019): S18–23. https://doi.org/10.1016/j.jval.2019.04.1914.
    Full Text Link to Item
  - Scott, Frank I., F Reed Johnson, Meenakshi Bewtra, Colleen M. Brensinger, Jason A. Roy, Shelby D. Reed, Mark T. Osterman, et al. “Improved Quality of Life With Anti-TNF Therapy Compared With Continued Corticosteroid Utilization in Crohn's Disease.” Inflamm Bowel Dis 25, no. 5 (April 11, 2019): 925–36. https://doi.org/10.1093/ibd/izy321.
    Full Text Link to Item
  - Johnson, F Reed, Jui-Chen Yang, and Shelby D. Reed. “The Internal Validity of Discrete Choice Experiment Data: A Testing Tool for Quantitative Assessments.” Value Health 22, no. 2 (February 2019): 157–60. https://doi.org/10.1016/j.jval.2018.07.876.
    Full Text Link to Item
  - Johnson, Reed F., Shelby Reed, and Juan Marcos Gonzalez. “Letter to the Editor Regarding Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.” Am J Gastroenterol 113, no. 11 (November 2018): 1720. https://doi.org/10.1038/s41395-018-0186-5.
    Full Text Link to Item
  - Gonzalez, Juan Marcos, F Reed Johnson, Bennett Levitan, Rebecca Noel, and Holly Peay. “Symposium Title: Preference Evidence for Regulatory Decisions.” Patient 11, no. 5 (October 2018): 467–73. https://doi.org/10.1007/s40271-018-0311-y.
    Full Text Link to Item
  - González, Juan Marcos, F Reed Johnson, Matthew Fedoruk, Joshua Posner, and Larry Bowers. “Trading Health Risks for Glory: A Reformulation of the Goldman Dilemma.” Sports Med 48, no. 8 (August 2018): 1963–69. https://doi.org/10.1007/s40279-018-0881-9.
    Full Text Link to Item
  - Wolka, Anne M., Angelyn O. Fairchild, Shelby D. Reed, Greg Anglin, F Reed Johnson, Michael Siegel, and Rebecca Noel. “Effective Partnering in Conducting Benefit-Risk Patient Preference Studies: Perspectives From a Patient Advocacy Organization, a Pharmaceutical Company, and Academic Stated-Preference Researchers.” Ther Innov Regul Sci 52, no. 4 (July 2018): 507–13. https://doi.org/10.1177/2168479017746404.
    Full Text Link to Item
  - Fairchild, Angelyn O., Shelby D. Reed, F Reed Johnson, Greg Anglin, Anne M. Wolka, and Rebecca A. Noel. “What is clearance worth? Patients' stated risk tolerance for psoriasis treatments.” J Dermatolog Treat 28, no. 8 (December 2017): 709–15. https://doi.org/10.1080/09546634.2017.1329499.
    Full Text Link to Item
  - Mühlbacher, Axel C., and F Reed Johnson. “Giving Patients a Meaningful Voice in European Health Technology Assessments: The Role of Health Preference Research.” Patient 10, no. 4 (August 2017): 527–30. https://doi.org/10.1007/s40271-017-0249-5.
    Full Text Link to Item
  - Johnson, F Reed, Kathleen Beusterien, Semra Özdemir, and Leslie Wilson. “Giving Patients a Meaningful Voice in United States Regulatory Decision Making: The Role for Health Preference Research.” Patient 10, no. 4 (August 2017): 523–26. https://doi.org/10.1007/s40271-017-0250-z.
    Full Text Link to Item
  - Arx, Lill-Brith von, F Reed Johnson, Morten Raun Mørkbak, and Trine Kjær. “Be Careful What You Ask For: Effects of Benefit Descriptions on Diabetes Patients' Benefit-Risk Tradeoff Preferences.” Value Health 20, no. 4 (April 2017): 670–78. https://doi.org/10.1016/j.jval.2016.11.023.
    Full Text Link to Item
  - Gonzalez, J. M., F. R. Johnson, H. McAteer, J. Posner, and F. Mughal. “Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment.” Br J Dermatol 176, no. 3 (March 2017): 777–85. https://doi.org/10.1111/bjd.14798.
    Full Text Link to Item
  - Marshall, Deborah A., Juan Marcos Gonzalez, Karen V. MacDonald, and F Reed Johnson. “Estimating Preferences for Complex Health Technologies: Lessons Learned and Implications for Personalized Medicine.” Value Health 20, no. 1 (January 2017): 32–39. https://doi.org/10.1016/j.jval.2016.08.737.
    Full Text Link to Item
  - Marshall, Deborah A., Juan Marcos Gonzalez, F Reed Johnson, Karen V. MacDonald, Amy Pugh, Michael P. Douglas, and Kathryn A. Phillips. “What are people willing to pay for whole-genome sequencing information, and who decides what they receive?” Genet Med 18, no. 12 (December 2016): 1295–1302. https://doi.org/10.1038/gim.2016.61.
    Full Text Link to Item
  - Mühlbacher, Axel C., Anika Kaczynski, Peter Zweifel, and F Reed Johnson. “Experimental measurement of preferences in health and healthcare using best-worst scaling: an overview.” Health Econ Rev 6, no. 1 (December 2016): 2. https://doi.org/10.1186/s13561-015-0079-x.
    Full Text Link to Item
  - Mühlbacher, Axel C., Peter Zweifel, Anika Kaczynski, and F Reed Johnson. “Experimental measurement of preferences in health care using best-worst scaling (BWS): theoretical and statistical issues.” Health Econ Rev 6, no. 1 (December 2016): 5. https://doi.org/10.1186/s13561-015-0077-z.
    Full Text Open Access Copy Link to Item
  - Ozdemir, S., F. R. Johnson, and D. Whittington. “Ideology, public goods and welfare valuation: An experiment on allocating government budgets.” Journal of Choice Modelling 20 (September 1, 2016): 61–72. https://doi.org/10.1016/j.jocm.2016.07.003.
    Full Text
  - Smith, Meredith Y., Tarek A. Hammad, Marilyn Metcalf, Bennett Levitan, Rebecca Noel, Anne M. Wolka, Debra L. Michaels, and F Reed Johnson. “Patient Engagement at a Tipping Point-The Need for Cultural Change Across Patient, Sponsor, and Regulator Stakeholders: Insights From the DIA Conference, "Patient Engagement in Benefit Risk Assessment Throughout the Life Cycle of Medical Products".” Ther Innov Regul Sci 50, no. 5 (September 2016): 546–53. https://doi.org/10.1177/2168479016662902.
    Full Text Link to Item
  - Mühlbacher, Axel, and F Reed Johnson. “Choice Experiments to Quantify Preferences for Health and Healthcare: State of the Practice.” Appl Health Econ Health Policy 14, no. 3 (June 2016): 253–66. https://doi.org/10.1007/s40258-016-0232-7.
    Full Text Link to Item
  - Mohamed, Ateesha Farah, F Reed Johnson, Maria-Magdalena Balp, and Frederico Calado. “Preferences and Stated Adherence for Antibiotic Treatment of Cystic Fibrosis Pseudomonas Infections.” Patient 9, no. 1 (February 2016): 59–67. https://doi.org/10.1007/s40271-015-0124-1.
    Full Text Link to Item
  - Cross, James, Jui-Chen Yang, F Reed Johnson, Jorge Quiroz, Judith Dunn, Melissa Raspa, and Donald B. Bailey. “Caregiver Preferences for the Treatment of Males with Fragile X Syndrome.” J Dev Behav Pediatr 37, no. 1 (January 2016): 71–79. https://doi.org/10.1097/DBP.0000000000000234.
    Full Text Link to Item
  - Johnson, F Reed, and Mo Zhou. “Patient Preferences in Regulatory Benefit-Risk Assessments: A US Perspective.” Value Health 19, no. 6 (2016): 741–45. https://doi.org/10.1016/j.jval.2016.04.008.
    Full Text Link to Item
  - Mühlbacher, Axel, F Reed Johnson, Jui-Chen Yang, Michael Happich, and Mark Belger. “Do You Want to Hear the Bad News? The Value of Diagnostic Tests for Alzheimer's Disease.” Value Health 19, no. 1 (January 2016): 66–74. https://doi.org/10.1016/j.jval.2015.10.011.
    Full Text Open Access Copy Link to Item
  - Bewtra, Meenakshi, Angelyn O. Fairchild, Erin Gilroy, David A. Leiman, Caroline Kerner, F Reed Johnson, and James D. Lewis. “Inflammatory Bowel Disease Patients' Willingness to Accept Medication Risk to Avoid Future Disease Relapse.” Am J Gastroenterol 110, no. 12 (December 2015): 1675–81. https://doi.org/10.1038/ajg.2015.321.
    Full Text Link to Item
  - Yang, J. C., F. R. Johnson, V. Kilambi, and A. F. Mohamed. “Sample size and utility-difference precision in discrete-choice experiments: A meta-simulation approach.” Journal of Choice Modelling 16 (September 1, 2015): 50–57. https://doi.org/10.1016/j.jocm.2015.09.001.
    Full Text
  - Levitan, Bennett, Michael Markowitz, Ateesha F. Mohamed, F Reed Johnson, Larry Alphs, Leslie Citrome, and John F. P. Bridges. “Patients' Preferences Related to Benefits, Risks, and Formulations of Schizophrenia Treatment.” Psychiatr Serv 66, no. 7 (July 2015): 719–26. https://doi.org/10.1176/appi.ps.201400188.
    Full Text Link to Item
  - Gonzalez, J. M., A. Brett Hauber, and F. Reed Johnson. “Estimating conditional certainty equivalents using choice-experiment data.” Journal of Choice Modelling 15 (June 1, 2015): 14–25. https://doi.org/10.1016/j.jocm.2015.05.001.
    Full Text
  - Zhang, J., F. Reed Johnson, A. F. Mohamed, and A. B. Hauber. “Too many attributes: A test of the validity of combining discrete-choice and best-worst scaling data.” Journal of Choice Modelling 15 (June 1, 2015): 1–13. https://doi.org/10.1016/j.jocm.2014.12.001.
    Full Text
  - Marshall, D. A., J. M. Gonzalez, F. R. Johnson, A. Pugh, K. V. MacDonald, M. P. Douglas, and K. A. Phillips. “What are people willing to pay for whole genome sequencing information?” Value in Health 18, no. 3 (May 2015): A285–86. https://doi.org/10.1016/j.jval.2015.03.1665.
    Full Text
  - Kauf, Teresa L., Jui-Chen Yang, Alexa B. Kimball, Murali Sundaram, Yanjun Bao, Martin Okun, Parvez Mulani, A Brett Hauber, and F Reed Johnson. “Psoriasis patients' willingness to accept side-effect risks for improved treatment efficacy.” J Dermatolog Treat 26, no. 6 (2015): 507–13. https://doi.org/10.3109/09546634.2015.1034071.
    Full Text Link to Item
  - Poulos, Christine, F. Reed Johnson, Girishanthy Krishnarajah, Andrea Anonychuk, and Derek Misurski. “Pediatricians' preferences for infant meningococcal vaccination.” Value Health 18, no. 1 (January 2015): 67–77. https://doi.org/10.1016/j.jval.2014.10.010.
    Full Text Link to Item
  - Kilambi, Vikram, F Reed Johnson, Juan Marcos González, and Ateesha F. Mohamed. “Valuations of genetic test information for treatable conditions: the case of colorectal cancer screening.” Value Health 17, no. 8 (December 2014): 838–45. https://doi.org/10.1016/j.jval.2014.09.001.
    Full Text Link to Item
  - Mühlbacher, A. C., F. R. Johnson, J. C. Yang, and M. Happich. “The Value of Diagnostic Tests for Alzheimer's Disease: Discrete-Choice Experiment and Contingent-Valuation.” Value Health 17, no. 7 (November 2014): A402. https://doi.org/10.1016/j.jval.2014.08.922.
    Full Text Link to Item
  - Shanks, T., R. W. F. Johnson, J. A. Schewtschenko, and J. R. Whitbourn. “A neutrino model fit to the CMB power spectrum.” Monthly Notices of the Royal Astronomical Society 445, no. 3 (September 5, 2014): 2836–41. https://doi.org/10.1093/mnras/stu1956.
    Full Text
  - Markowitz, Michael A., Bennett S. Levitan, Ateesha F. Mohamed, F. R. Johnson, John F. P. Bridges, Larry Alphs, and Leslie Citrome. “Psychiatrists' judgments about antipsychotic benefit and risk outcomes and formulation in schizophrenia treatment.” Psychiatr Serv 65, no. 9 (September 1, 2014): 1133–39. https://doi.org/10.1176/appi.ps.201300290.
    Full Text Link to Item
  - Hauber, A Brett, Ateesha F. Mohamed, F Reed Johnson, Michael Cook, H Michael Arrighi, Jing Zhang, and Michael Grundman. “Understanding the relative importance of preserving functional abilities in Alzheimer's disease in the United States and Germany.” Qual Life Res 23, no. 6 (August 2014): 1813–21. https://doi.org/10.1007/s11136-013-0620-5.
    Full Text Link to Item
  - Bewtra, Meenakshi, Vikram Kilambi, Angelyn O. Fairchild, Corey A. Siegel, James D. Lewis, and F Reed Johnson. “Patient preferences for surgical versus medical therapy for ulcerative colitis.” Inflamm Bowel Dis 20, no. 1 (January 2014): 103–14. https://doi.org/10.1097/01.MIB.0000437498.14804.50.
    Full Text Link to Item
  - Brown, Derek S., Christine Poulos, F Reed Johnson, Linda Chamiec-Case, and Mark L. Messonnier. “Adolescent girls' preferences for HPV vaccines: a discrete choice experiment.” Adv Health Econ Health Serv Res 24 (2014): 93–121.
    Link to Item
  - Poulos, Christine, Juan Marcos González, Lauren J. Lee, Kristin S. Boye, F Reed Johnson, Jay P. Bae, and Mark A. Deeg. “Physician preferences for extra-glycemic effects of type 2 diabetes treatments.” Diabetes Ther 4, no. 2 (December 2013): 443–59. https://doi.org/10.1007/s13300-013-0046-7.
    Full Text Link to Item
  - González, J. M., F. R. Johnson, A. Fairchild, T. Irony, and M. Ho. “Patients at the Center of Regulatory Decisions: Using Stated-Preference Data to Help Regulators Answer Difficult Questions.” Value in Health 16, no. 7 (November 2013): A387–A387. https://doi.org/10.1016/j.jval.2013.08.370.
    Full Text
  - González, J. M., F. R. Johnson, and F. Mughal. “Psoriasis Patients’ Tolerance for Therapeutic Risks in Return for Symptom Improvement in the United Kingdom.” Value in Health 16, no. 7 (November 2013): A508–A508. https://doi.org/10.1016/j.jval.2013.08.1178.
    Full Text
  - Mohamed, A. F., F. R. Johnson, M. M. Balp, and F. Calado. “Which Cystic Fibrosis Inhaled Antibiotic Medicine Features Matter Most to Adult Patients and Parents of Pediatric Patients?” Value in Health 16, no. 7 (November 2013): A722–A722. https://doi.org/10.1016/j.jval.2013.08.2251.
    Full Text
  - Mohamed, A. F., J. Zhang, F. R. Johnson, I Duprat Lomon, E. Malvolti, R. Townsend, C. J. Ostgren, and K. G. Parhofer. “Avoidance of weight gain is important for oral type 2 diabetes treatments in Sweden and Germany: patient preferences.” Diabetes Metab 39, no. 5 (October 2013): 397–403. https://doi.org/10.1016/j.diabet.2013.06.001.
    Full Text Link to Item
  - Brett Hauber, A., Angelyn O. Fairchild, and F. Reed Johnson. “Quantifying benefit-risk preferences for medical interventions: an overview of a growing empirical literature.” Appl Health Econ Health Policy 11, no. 4 (August 2013): 319–29. https://doi.org/10.1007/s40258-013-0028-y.
    Full Text Link to Item
  - Özdemir, S., and F. R. Johnson. “Estimating willingness to pay: Do health and environmental researchers have different methodological standards?” Applied Economics 45, no. 16 (June 1, 2013): 2215–29. https://doi.org/10.1080/00036846.2012.659345.
    Full Text Open Access Copy
  - Mohamed, A. F., F. R. Johnson, J. M. González, and M. M. Balp. “Stated time-allocation, adherence, and health-outcome tradeoff preferences in cystic fibrosis households.” Value in Health 16, no. 3 (May 2013): A26–A26. https://doi.org/10.1016/j.jval.2013.03.154.
    Full Text
  - Hauber, A. B., N. K. Arden, A. F. Mohamed, F. R. Johnson, P. M. Peloso, D. J. Watson, P. Mavros, A. Gammaitoni, S. S. Sen, and S. D. Taylor. “A discrete-choice experiment of United Kingdom patients' willingness to risk adverse events for improved function and pain control in osteoarthritis.” Osteoarthritis Cartilage 21, no. 2 (February 2013): 289–97. https://doi.org/10.1016/j.joca.2012.11.007.
    Full Text Link to Item
  - Bewtra, Meenakshi, and F Reed Johnson. “Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative data.” Patient 6, no. 4 (2013): 241–55. https://doi.org/10.1007/s40271-013-0031-2.
    Full Text Link to Item
  - Gonzalez, Juan M., F Reed Johnson, Michael C. Runken, and Christine M. Poulos. “Evaluating migraineurs' preferences for migraine treatment outcomes using a choice experiment.” Headache 53, no. 10 (2013): 1635–50. https://doi.org/10.1111/head.12142.
    Full Text Link to Item
  - Reed Johnson, F., Emily Lancsar, Deborah Marshall, Vikram Kilambi, Axel Mühlbacher, Dean A. Regier, Brian W. Bresnahan, Barbara Kanninen, and John F. P. Bridges. “Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force.” Value Health 16, no. 1 (2013): 3–13. https://doi.org/10.1016/j.jval.2012.08.2223.
    Full Text Link to Item
  - Mohamed, A., J. Zhang, F. R. Johnson, I. Duprat lomon, E. Malvoti, C. J. Ostgren, and K. G. Parhofer. “PDB64 The Avoidance of Weight Gain is Important for Oral Type 2 Diabetes Treatments in Sweden and Germany: A Patient Preference Study.” Value in Health 15, no. 7 (November 2012): A505–A505. https://doi.org/10.1016/j.jval.2012.08.1707.
    Full Text
  - Marshall, D., F. R. Johnson, S. Ozdemir, N. A. Kulin, and V. Kilambi. “PMD46 Doctor Knows Best: The Effect of Yea-Saying Bias on Willingness to Pay in Choice-Format Conjoint-Analysis Studies.” Value in Health 15, no. 4 (June 2012): A70–A70. https://doi.org/10.1016/j.jval.2012.03.386.
    Full Text
  - Yang, J. C., and F. R. Johnson. “PND35 Fictitious Preferences or Felicitous Recoding? Conjoint Respondents Who Make Sense of Nonsensical Questions.” Value in Health 15, no. 4 (June 2012): A147–A147. https://doi.org/10.1016/j.jval.2012.03.794.
    Full Text
  - Arden, Nigel K., A Brett Hauber, Ateesha F. Mohamed, F Reed Johnson, Paul M. Peloso, Douglas J. Watson, Panagiotis Mavros, Arnold Gammaitoni, Shuvayu S. Sen, and Stephanie D. Taylor. “How do physicians weigh benefits and risks associated with treatments in patients with osteoarthritis in the United Kingdom?” J Rheumatol 39, no. 5 (May 2012): 1056–63. https://doi.org/10.3899/jrheum.111066.
    Full Text Link to Item
  - Mohamed, Ateesha Farah, F Reed Johnson, A Brett Hauber, Benedicte Lescrauwaet, and Allan Masterson. “Physicians' stated trade-off preferences for chronic hepatitis B treatment outcomes in Germany, France, Spain, Turkey, and Italy.” Eur J Gastroenterol Hepatol 24, no. 4 (April 2012): 419–26. https://doi.org/10.1097/MEG.0b013e328350914c.
    Full Text Link to Item
  - Johnson, F Reed. “Why not real economics?” Pharmacoeconomics 30, no. 2 (February 1, 2012): 127–31. https://doi.org/10.2165/11593350-000000000-00000.
    Full Text Link to Item
  - Gonzalez, J. M., F. R. Johnson, M. C. Runken, and C. Poulos. “PSY38 Estimating Healthy-Time Equivalents for Migraine Treatment Outcomes from Conjoint Analysis Measures of Patient Preferences.” Value in Health 14, no. 7 (November 2011): A417–A417. https://doi.org/10.1016/j.jval.2011.08.1010.
    Full Text
  - Mohamed, A., F. R. Johnson, A. B. Hauber, B. Lescrauwaet, and M. Saylan. “PIN89 Do Patients and Physicians Have Similar Preferences Chronic Hepatitis B Treatment Outcomes in Turkey?” Value in Health 14, no. 7 (November 2011): A282–A282. https://doi.org/10.1016/j.jval.2011.08.275.
    Full Text
  - Hauber, A Brett, Robbin Itzler, F Reed Johnson, Ateesha F. Mohamed, Juan Marcos González, John R. Cook, and Emmanuel B. Walter. “Healthy-days time equivalents for outcomes of acute rotavirus infections.” Vaccine 29, no. 45 (October 19, 2011): 8086–93. https://doi.org/10.1016/j.vaccine.2011.08.041.
    Full Text Link to Item
  - Bridges, John F. P., A Brett Hauber, Deborah Marshall, Andrew Lloyd, Lisa A. Prosser, Dean A. Regier, F Reed Johnson, and Josephine Mauskopf. “Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force.” Value Health 14, no. 4 (June 2011): 403–13. https://doi.org/10.1016/j.jval.2010.11.013.
    Full Text Link to Item
  - Lescrauwaet, B., A. F. Mohamed, F. R. Johnson, and A. B. Hauber. “PIN40 DO PATIENTS AND PHYSICIANS HAVE SIMILAR PREFERENCES FOR HEALTH CARE DECISIONS INVOLVING UNCERTAIN OUTCOMES FOR CHRONIC HEPATITIS B IN GERMANY AND TURKEY?” Value in Health 14, no. 3 (May 2011): A121–A121. https://doi.org/10.1016/j.jval.2011.02.671.
    Full Text
  - Mohamed, A. F., F. R. Johnson, and S. J. Knight. “PMD34 PREFERENCES FOR GENETIC TESTING TO ASSESS COLON-CANCER RISKS.” Value in Health 14, no. 3 (May 2011): A84–A84. https://doi.org/10.1016/j.jval.2011.02.471.
    Full Text
  - Johnson, F Reed, Ateesha F. Mohamed, Semra Ozdemir, Deborah A. Marshall, and Kathryn A. Phillips. “How does cost matter in health-care discrete-choice experiments?” Health Econ 20, no. 3 (March 2011): 323–30. https://doi.org/10.1002/hec.1591.
    Full Text Link to Item
  - Van Houtven, George, F Reed Johnson, Vikram Kilambi, and A Brett Hauber. “Eliciting benefit-risk preferences and probability-weighted utility using choice-format conjoint analysis.” Med Decis Making 31, no. 3 (2011): 469–80. https://doi.org/10.1177/0272989X10386116.
    Full Text Link to Item
  - Marshall, Deborah, John F. P. Bridges, Brett Hauber, Ruthanne Cameron, Lauren Donnalley, Ken Fyie, and F Reed Johnson. “Conjoint Analysis Applications in Health - How are Studies being Designed and Reported?: An Update on Current Practice in the Published Literature between 2005 and 2008.” Patient 3, no. 4 (December 1, 2010): 249–56. https://doi.org/10.2165/11539650-000000000-00000.
    Full Text Link to Item
  - Mohamed, Ateesha F., A Brett Hauber, F Reed Johnson, and Cheryl D. Coon. “Patient preferences and linear scoring rules for patient-reported outcomes.” Patient 3, no. 4 (December 1, 2010): 217–27. https://doi.org/10.2165/11537880-000000000-00000.
    Full Text Link to Item
  - Bridges, J. F., S. D. Taylor, N. Arden, A. B. Hauber, F. R. Johnson, D. Watson, P. Mavros, et al. “PMS52 PREFERENCES OVER BENEFITS AND RISKS ASSOCIATED WITH THE USE OF NSAIDS: EVIDENCE FROM PATIENTS DIAGNOSED WITH OSTEOARTHRITIS (OA) IN UK.” Value in Health 13, no. 7 (November 2010): A312–A312. https://doi.org/10.1016/s1098-3015(11)72205-7.
    Full Text
  - Bridges, J. F., S. D. Taylor, N. Arden, A. B. Hauber, F. R. Johnson, D. Watson, P. Mavros, et al. “PMS68 PHYSICIANS' STATED PREFERENCES OVER BENEFITS AND RISKS ASSOCIATED WITH NSAID USE IN PATIENTS WITH OSTEOARTHRITIS IN UNITED KINGDOM.” Value in Health 13, no. 7 (November 2010): A316–A316. https://doi.org/10.1016/s1098-3015(11)72221-5.
    Full Text
  - Johnson, F. R., J. M. Gonzalez, and A. B. Hauber. “PMS50 PATIENTS' STATED HEALTH-OUTCOME PREFERENCES FOR CONFOUNDED PATIENT-REPORTED OUTCOME DOMAINS FOR OSTEOARTHRITIS.” Value in Health 13, no. 7 (November 2010): A312–A312. https://doi.org/10.1016/s1098-3015(11)72203-3.
    Full Text
  - Johnson, F Reed, Brett Hauber, Semra Özdemir, Corey A. Siegel, Steven Hass, and Bruce E. Sands. “Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn's disease management.” J Manag Care Pharm 16, no. 8 (October 2010): 616–28. https://doi.org/10.18553/jmcp.2010.16.8.616.
    Full Text Link to Item
  - Hauber, A Brett, Ateesha F. Mohamed, F Reed Johnson, Olatoye Oyelowo, Bradley H. Curtis, and Cheryl Coon. “Estimating importance weights for the IWQOL-Lite using conjoint analysis.” Qual Life Res 19, no. 5 (June 2010): 701–9. https://doi.org/10.1007/s11136-010-9621-9.
    Full Text Link to Item
  - Hauber, A. B., A. F. Mohamed, F. R. Johnson, and M. Neary. “Patient preferences for targeted agents in renal cell carcinoma (RCC): A benefit–risk conjoint study.” Journal of Clinical Oncology 28, no. 15_suppl (May 20, 2010): 4596–4596. https://doi.org/10.1200/jco.2010.28.15_suppl.4596.
    Full Text
  - Hauber, A. B., A. F. Mohamed, F. R. Johnson, and M. P. Neary. “PCN110 HOW MUCH DO PATIENTS WITH RENAL CELL CARCINOMA (RCC) VALUE PROGRESSION FREE SURVIVAL IN MEDICAL DECISION MAKING?–RESULTS FROM A BENEFIT-RISK CONJOINT STUDY.” Value in Health 13, no. 3 (May 2010): A44–45. https://doi.org/10.1016/s1098-3015(10)72199-9.
    Full Text
  - Johnson, F. R., A. B. Hauber, J. M. Gonzalez, B. Levitan, and P. Copland. “PMC29 PATIENT PREFERENCE WEIGHTS FOR BENEFIT-RISK ANALYSIS: A STATIN CASE STUDY.” Value in Health 13, no. 3 (May 2010): A19–A19. https://doi.org/10.1016/s1098-3015(10)72072-6.
    Full Text
  - Hauber, A Brett, F Reed Johnson, Kelly M. Grotzinger, and Semra Ozdemir. “Patients' benefit-risk preferences for chronic idiopathic thrombocytopenic purpura therapies.” Ann Pharmacother 44, no. 3 (March 2010): 479–88. https://doi.org/10.1345/aph.1M567.
    Full Text Link to Item
  - Brown, Derek S., F Reed Johnson, Christine Poulos, and Mark L. Messonnier. “Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus.” Vaccine 28, no. 7 (February 17, 2010): 1702–8. https://doi.org/10.1016/j.vaccine.2009.12.024.
    Full Text Link to Item
  - Johnson, F Reed, A Brett Hauber, Semra Ozdemir, and Larry Lynd. “Quantifying women's stated benefit-risk trade-off preferences for IBS treatment outcomes.” Value Health 13, no. 4 (2010): 418–23. https://doi.org/10.1111/j.1524-4733.2010.00694.x.
    Full Text Link to Item
  - Johnson, F Reed, Semra Ozdemir, and Kathryn A. Phillips. “Effects of simplifying choice tasks on estimates of taste heterogeneity in stated-choice surveys.” Soc Sci Med 70, no. 2 (January 2010): 183–90. https://doi.org/10.1016/j.socscimed.2009.10.021.
    Full Text Link to Item
  - Lynd, Larry D., Mehdi Najafzadeh, Lindsey Colley, Michael F. Byrne, Andrew R. Willan, Mark J. Sculpher, F Reed Johnson, and A Brett Hauber. “Using the incremental net benefit framework for quantitative benefit-risk analysis in regulatory decision-making--a case study of alosetron in irritable bowel syndrome.” Value Health 13, no. 4 (2010): 411–17. https://doi.org/10.1111/j.1524-4733.2009.00595.x.
    Full Text Link to Item
  - Ozdemir, Semra, Ateesha F. Mohamed, F Reed Johnson, and A Brett Hauber. “Who pays attention in stated-choice surveys?” Health Econ 19, no. 1 (January 2010): 111–18. https://doi.org/10.1002/hec.1452.
    Full Text Link to Item
  - Marshall, Deborah A., F Reed Johnson, Nathalie A. Kulin, Semra Ozdemir, Judith M. E. Walsh, John K. Marshall, Stephanie Van Bebber, and Kathryn A. Phillips. “How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey.” Health Econ 18, no. 12 (December 2009): 1420–39. https://doi.org/10.1002/hec.1437.
    Full Text Link to Item
  - Johnson, F. R., A. B. Hauber, A. F. Mohamed, and J. M. Gonzalez. “PATIENT PREFERENCES FOR BENEFIT-RISK TRADEOFFS AMONG POST-TRANSPLANT OUTCOMES IN END-STAGE RENAL DISEASE.” Value in Health 12, no. 7 (October 1, 2009): A227–A227.
    Link to Item
  - Johnson, F. R., V. K. Smith, G. A. Smith, and J. M. Gonzalez. “LIVES WORTH LIVING: OLDER SMOKERS' STATED PREFERENCES FOR LONGEVITY.” Value in Health 12, no. 7 (October 1, 2009): A227–28.
    Link to Item
  - Hauber, A. B., F. R. Johnson, J. R. Cook, A. F. Mohamed, J. M. Gonzalez, and E. Walter. “UT3 HEALTHY-DAYS TIME EQUIVALENTS FOR OUTCOMES OF ACUTE ROTAVIRUS INFECTIONS.” Value in Health 12, no. 7 (October 2009): A224–A224. https://doi.org/10.1016/s1098-3015(10)74094-8.
    Full Text
  - Lloyd, A., J. F. Bridges, and F. R. Johnson. “PMC70 CLASSIFYING PATIENT REPORTED OUTCOMES: DEVELOPMENTS IN THE FIELD SUGGEST A NEW TAXONOMY.” Value in Health 12, no. 7 (October 2009): A400–A400. https://doi.org/10.1016/s1098-3015(10)74972-x.
    Full Text
  - Mohamed, A. F., A. B. Hauber, and F. R. Johnson. “PR4 LINEAR SCORING RULES FOR PATIENT REPORTED OUTCOMES AND PATIENT PREFERENCES.” Value in Health 12, no. 7 (October 2009): A232–A232. https://doi.org/10.1016/s1098-3015(10)74131-0.
    Full Text
  - Ozdemir, Semra, F Reed Johnson, and A Brett Hauber. “Hypothetical bias, cheap talk, and stated willingness to pay for health care.” J Health Econ 28, no. 4 (July 2009): 894–901. https://doi.org/10.1016/j.jhealeco.2009.04.004.
    Full Text Link to Item
  - Marshall, D. A., A. B. Hauber, J. F. Bridges, R. Cameron, L. Weaver, J. Dionne, and F. R. Johnson. “PMC62 ASSESSING THE QUALITY OF CONJOINT ANALYSIS APPLICATIONS IN HEALTH: A PILOT EVALUATION OF THE ISPOR CHECKLIST FOR GOOD RESEARCH PRACTICE IN CONJOINT ANALYSIS.” Value in Health 12, no. 3 (May 2009): A31–A31. https://doi.org/10.1016/s1098-3015(10)73213-7.
    Full Text
  - Hauber, A. B., A. F. Mohamed, F. R. Johnson, and H. Falvey. “Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents.” Diabet Med 26, no. 4 (April 2009): 416–24. https://doi.org/10.1111/j.1464-5491.2009.02696.x.
    Full Text Link to Item
  - Johnson, F Reed, George Van Houtven, Semra Ozdemir, Steve Hass, Jeff White, Gordon Francis, David W. Miller, and J Theodore Phillips. “Multiple sclerosis patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy.” J Neurol 256, no. 4 (April 2009): 554–62. https://doi.org/10.1007/s00415-009-0084-2.
    Full Text Link to Item
  - Brown, Derek S., Eric A. Finkelstein, David R. Brown, David M. Buchner, and F Reed Johnson. “Estimating older adults' preferences for walking programs via conjoint analysis.” Am J Prev Med 36, no. 3 (March 2009): 201-7.e4. https://doi.org/10.1016/j.amepre.2008.10.014.
    Full Text Link to Item
  - Johnson, F Reed. “Editorial: Moving the QALY forward or just stuck in traffic?” Value Health 12 Suppl 1 (March 2009): S38–39. https://doi.org/10.1111/j.1524-4733.2009.00521.x.
    Full Text Link to Item
  - Hauber, A Brett, Ateesha F. Mohamed, F Reed Johnson, David Meddis, Samuel Wagner, and Liza O’Dowd. “Quantifying asthma patient preferences for onset of effect of combination inhaled corticosteroids and long-acting beta2-agonist maintenance medications.” Allergy Asthma Proc 30, no. 2 (2009): 139–47. https://doi.org/10.2500/aap.2009.30.3205.
    Full Text Link to Item
  - Hauber, A Brett, Ateesha F. Mohamed, Maria E. Watson, F Reed Johnson, and Jaime E. Hernandez. “Benefits, risk, and uncertainty: preferences of antiretroviral-naïve African Americans for HIV treatments.” Aids Patient Care Stds 23, no. 1 (January 2009): 29–34. https://doi.org/10.1089/apc.2008.0064.
    Full Text Link to Item
  - Hauber, A Brett, F Reed Johnson, Howard Fillit, Ateesha F. Mohamed, Christopher Leibman, H Michael Arrighi, Michael Grundman, and Raymond J. Townsend. “Older Americans' risk-benefit preferences for modifying the course of Alzheimer disease.” Alzheimer Dis Assoc Disord 23, no. 1 (2009): 23–32. https://doi.org/10.1097/WAD.0b013e318181e4c7.
    Full Text Link to Item
  - Johnson, F Reed, A Brett Hauber, and Semra Ozdemir. “Using conjoint analysis to estimate healthy-year equivalents for acute conditions: an application to vasomotor symptoms.” Value Health 12, no. 1 (2009): 146–52. https://doi.org/10.1111/j.1524-4733.2008.00391.x.
    Full Text Link to Item
  - Johnson, F Reed, Semra Ozdemir, Carol Mansfield, Steven Hass, Corey A. Siegel, and Bruce E. Sands. “Are adult patients more tolerant of treatment risks than parents of juvenile patients?” Risk Anal 29, no. 1 (January 2009): 121–36. https://doi.org/10.1111/j.1539-6924.2008.01135.x.
    Full Text Link to Item
  - Johnson, F Reed. “Why not ask?: measuring patient preferences for healthcare decision making.” Patient 1, no. 4 (December 1, 2008): 245–48. https://doi.org/10.2165/01312067-200801040-00003.
    Full Text Link to Item
  - Johnson, F Reed, and Carol Mansfield. “Survey-design and analytical strategies for better healthcare stated-choice studies.” Patient 1, no. 4 (December 1, 2008): 299–307. https://doi.org/10.2165/1312067-200801040-00011.
    Full Text Link to Item
  - Grotzinger, Kelly M., F Reed Johnson, A Brett Hauber, Semra Özdemir, and Mohan V. Bala. “Patients Are Willing to Trade off Efficacy, Safety, and Administration Attributes of Chronic Idiopathic Purpura (ITP) Therapy: Results from a Large North American Discrete Choice Study.” Blood 112, no. 11 (November 16, 2008): 669–669. https://doi.org/10.1182/blood.v112.11.669.669.
    Full Text
  - Mohamed, A. F., A. B. Hauber, F. R. Johnson, D. Meddis, and S. Wagner. “PMC28 STATUS-QUO BIAS IN STATED-CHOICE STUDIES: IS IT REAL?” Value in Health 11, no. 6 (November 2008): A567–68. https://doi.org/10.1016/s1098-3015(10)66867-2.
    Full Text
  - Johnson, F Reed. “Why Not Ask?” The Patient: Patient Centered Outcomes Research 1, no. 4 (October 2008): 245–48. https://doi.org/10.2165/1312067-200801040-00003.
    Full Text
  - Harmon, Bruno, Michael Arrighi, Reed Johnson, and Susana Perez. “Evaluating quantitative benefit-risk analysis for drug-approval decision making in Europe and the United States.” Pharmacoepidemiology and Drug Safety 17 (August 1, 2008): S26–S26.
    Link to Item
  - Hauber, A. B., A. F. Mohamed, F. R. Johnson, H. Falvey, and E. Snyder. “PDB56 PREFERENCES FOR ORAL ANTIDIABETIC AGENTS AMONG PEOPLE WITH TYPE 2 DIABETES.” Value in Health 11, no. 3 (May 2008): A233–A233. https://doi.org/10.1016/s1098-3015(10)70739-7.
    Full Text
  - Mohamed, A. F., F. R. Johnson, A. B. Hauber, D. Meddis, and S. Wagner. “PRS26 PREFERENCES FOR ONSET OF EFFECT OF COMBINATION MAINTENANCE MEDICATION AMONG ASTHMA PATIENTS.” Value in Health 11, no. 3 (May 2008): A277–A277. https://doi.org/10.1016/s1098-3015(10)70874-3.
    Full Text
  - Brown, D. S., F. R. Johnson, C. Poulos, and M. L. Messonnier. “Mother and daughter preferences and willingness to pay for HPV vaccination.” Vaccine, January 1, 2008.
    Link to Item
  - Mansfield, C., D. J. Phaneuf, F. R. Johnson, J. C. Yang, and R. Beach. “Preferences for public lands management under competing uses: The case of Yellowstone National Park.” Land Economics 84, no. 2 (January 1, 2008): 282–305. https://doi.org/10.3368/le.84.2.282.
    Full Text
  - Johnson, F. R., S. Ozdemir, C. Mansfield, A. B. Hauber, S. L. Hass, C. A. Siegel, B. E. Sands, and D. W. Miller. “PR3 PATIENTS', PARENTS', AND PHYSICIANS' RISK-BENEFIT TRADE-OFF PREFERENCES FOR CROHN'S DISEASE TREATMENTS.” Value in Health 10, no. 6 (November 2007): A225–26. https://doi.org/10.1016/s1098-3015(10)64868-1.
    Full Text
  - Marshall, D. A., F. R. Johnson, N. A. Kulin, S. Ozdemir, J. K. Marshall, J. Walsh, S. Van Bebber, and K. A. Phillips. “PCN76 COMPARISON OF PHYSICIAN AND PATIENT PREFERENCES FOR COLORECTAL CANCER SCREENING USING A DISCRETE CHOICE EXPERIMENT.” Value in Health 10, no. 6 (November 2007): A346–A346. https://doi.org/10.1016/s1098-3015(10)65234-5.
    Full Text
  - Mohamed, A. F., A. B. Hauber, F. R. Johnson, M. E. Watson, and J. E. Hernandez. “PIN44 INCORPORATING PROBABILISTIC ATTRIBUTES IN A STATED-CHOICE RISK-BENEFIT SURVEY.” Value in Health 10, no. 6 (November 2007): A449–A449. https://doi.org/10.1016/s1098-3015(10)65551-9.
    Full Text
  - Johnson, F Reed, Semra Ozdemir, Brett Hauber, and Teresa L. Kauf. “Women's willingness to accept perceived risks for vasomotor symptom relief.” J Womens Health (Larchmt) 16, no. 7 (September 2007): 1028–40. https://doi.org/10.1089/jwh.2006.0218.
    Full Text Link to Item
  - Johnson, F Reed, Semra Ozdemir, Carol Mansfield, Steven Hass, David W. Miller, Corey A. Siegel, and Bruce E. Sands. “Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy.” Gastroenterology 133, no. 3 (September 2007): 769–79. https://doi.org/10.1053/j.gastro.2007.04.075.
    Full Text Link to Item
  - Lynd, Larry D., Lindsey Colley, Mehdi Najafzedeh, Mark J. Sculpher, Andrew R. Willan, Reed F. Johnson, and Semra Ozdemir. “Quantitative risk-benefit analysis of alosetron in irritiable bowel syndrome: A patient-level meta-cohort analysis.” Pharmacoepidemiology and Drug Safety 16 (August 1, 2007): S183–S183.
    Link to Item
  - Johnson, F Reed, Semra Ozdemir, Ranjani Manjunath, A Brett Hauber, Steven P. Burch, and Thomas R. Thompson. “Factors that affect adherence to bipolar disorder treatments: a stated-preference approach.” Med Care 45, no. 6 (June 2007): 545–52. https://doi.org/10.1097/MLR.0b013e318040ad90.
    Full Text Link to Item
  - Cook, J., D. Whittington, D. G. Canh, F. R. Johnson, and A. Nyamete. “Reliability of stated preferences for cholera and typhoid vaccines with time to think in Hue, Vietnam.” Economic Inquiry 45, no. 1 (January 1, 2007): 100–114. https://doi.org/10.1093/ei/cbl005.
    Full Text
  - Marshall, Deborah A., F Reed Johnson, Kathryn A. Phillips, John K. Marshall, Lehana Thabane, and Nathalie A. Kulin. “Measuring patient preferences for colorectal cancer screening using a choice-format survey.” Value Health 10, no. 5 (2007): 415–30. https://doi.org/10.1111/j.1524-4733.2007.00196.x.
    Full Text Link to Item
  - Johnson, F. R., B. Hauber, and S. Ozdemir. “PIH20 CONJOINT-ANALYSIS QALYS FOR ACUTE CONDITIONS.” Value in Health 9, no. 6 (November 2006): A258–A258. https://doi.org/10.1016/s1098-3015(10)63378-5.
    Full Text
  - Johnson, F. R., S. Ozdemir, C. Mansfield, S. L. Hass, and T. J. White. “PGI16 ARE ADULTS MORE AVERSE TO TREATMENT RISKS FOR THEIR CHILDREN THAN THEY ARE FOR THEMSELVES?” Value in Health 9, no. 6 (November 2006): A246–A246. https://doi.org/10.1016/s1098-3015(10)63340-2.
    Full Text
  - Johnson, F Reed, Semra Ozdemir, and Elizabeth B. Andrews. “Patients willingness to accept risk-benefit trade-offs in treating Crohn's disease.” Pharmacoepidemiology and Drug Safety 15 (August 1, 2006): S138–39.
    Link to Item
  - Mansfield, C., F. Reed Johnson, and G. Van Houtven. “The missing piece: Valuing averting behavior for children's ozone exposures.” Resource and Energy Economics 28, no. 3 (August 1, 2006): 215–28. https://doi.org/10.1016/j.reseneeco.2006.02.002.
    Full Text
  - Reed Johnson, F., Teresa Kauf, and Elizabeth B. Andrews. “Willingness to accept risk-benefit tradeoffs: Pharmacoepidemiology meets preference measurement.” Pharmacoepidemiology and Drug Safety 15 (August 1, 2006): S36–37.
    Link to Item
  - Johnson, F Reed, Ranjani Manjunath, Carol A. Mansfield, Laurel J. Clayton, Thomas J. Hoerger, and Ping Zhang. “High-risk individuals' willingness to pay for diabetes risk-reduction programs.” Diabetes Care 29, no. 6 (June 2006): 1351–56. https://doi.org/10.2337/dc05-2221.
    Full Text Link to Item
  - Johnson, F. R. “Comment on "revealing differences in willingness to pay due to the dimensionality of stated choice designs: An initial assessment".” Environmental and Resource Economics 34, no. 1 (May 1, 2006): 45–50. https://doi.org/10.1007/s10640-005-3783-x.
    Full Text
  - Johnson, F Reed, A Brett Hauber, David Osoba, Ming-Ann Hsu, John Coombs, and Catherine Copley-Merriman. “Are chemotherapy patients' HRQoL importance weights consistent with linear scoring rules? A stated-choice approach.” Qual Life Res 15, no. 2 (March 2006): 285–98. https://doi.org/10.1007/s11136-005-0581-4.
    Full Text Link to Item
  - Osoba, David, Ming-Ann Hsu, Catherine Copley-Merriman, John Coombs, F Reed Johnson, Brett Hauber, Ranjani Manjunath, and Amanda Pyles. “Stated preferences of patients with cancer for health-related quality-of-life (HRQOL) domains during treatment.” Qual Life Res 15, no. 2 (March 2006): 273–83. https://doi.org/10.1007/s11136-005-0580-5.
    Full Text Link to Item
  - Johnson, F Reed, and Martin Backhouse. “Eliciting stated preferences for health-technology adoption criteria using paired comparisons and recommendation judgments.” Value Health 9, no. 5 (2006): 303–11. https://doi.org/10.1111/j.1524-4733.2006.00119.x.
    Full Text Link to Item
  - Adamowicz, W., M. Hanemann, J. Swait, R. Johnson, D. Layton, M. Regenwetter, T. Reimer, and R. Sorkin. “Decision strategy and structure in households: A "groups" perspective.” Marketing Letters 16, no. 3–4 (December 1, 2005): 387–99. https://doi.org/10.1007/s11002-005-5900-6.
    Full Text
  - Hauber, A Brett, F Reed Johnson, Luc Sauriol, and Benedicte Lescrauwaet. “Risking health to avoid injections: preferences of Canadians with type 2 diabetes.” Diabetes Care 28, no. 9 (September 2005): 2243–45. https://doi.org/10.2337/diacare.28.9.2243.
    Full Text Link to Item
  - Johnson, F. R., A. B. Hauber, and S. Ozdemir. “QLI IS RELIEF WORTH THE RISK? RISK-BENEFIT PREFERENCES FOR TREATMENTS FORVASOMOTOR SYMPTOMS.” Value in Health 8, no. 3 (May 2005): 244–45. https://doi.org/10.1016/s1098-3015(10)62594-6.
    Full Text
  - Johnson, F Reed. “Einstein on willingness to pay per QALY: is there a better way?” Med Decis Making 25, no. 6 (2005): 607–8. https://doi.org/10.1177/0272989X05283084.
    Full Text Link to Item
  - “40th EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004.” Diabetologia 47, no. Suppl 1 (August 2004): A1–464. https://doi.org/10.1007/BF03375463.
    Full Text Link to Item
  - Maddala, Tara, Kathryn A. Phillips, and F. Reed Johnson. “An experiment on simplifying conjoint analysis designs for measuring preferences.” Health Econ 12, no. 12 (December 2003): 1035–47. https://doi.org/10.1002/hec.798.
    Full Text Link to Item
  - Hauber, A. B., and F. R. Johnson. “PDB27: RISKING HEALTH TO AVOIDING INJECTIONS—STATED PREFERENCES OF TYPE 2 DIABETICS IN THE US AND CANADA.” Value in Health 6, no. 3 (May 2003): 337–337. https://doi.org/10.1016/s1098-3015(10)64192-7.
    Full Text
  - Stieb, David M., Paul De Civita, F Reed Johnson, Matthew P. Manary, Aslam H. Anis, Robert C. Beveridge, and Stan Judek. “Economic evaluation of the benefits of reducing acute cardiorespiratory morbidity associated with air pollution.” Environ Health 1, no. 1 (December 18, 2002): 7. https://doi.org/10.1186/1476-069x-1-7.
    Full Text Link to Item
  - Phillips, Kathryn A., F Reed Johnson, and Tara Maddala. “Measuring what people value: a comparison of "attitude" and "preference" surveys.” Health Serv Res 37, no. 6 (December 2002): 1659–79. https://doi.org/10.1111/1475-6773.01116.
    Full Text Link to Item
  - Phillips, Kathryn A., Tara Maddala, and F Reed Johnson. “Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing.” Health Serv Res 37, no. 6 (December 2002): 1681–1705. https://doi.org/10.1111/1475-6773.01115.
    Full Text Link to Item
  - Johnson, F Reed, and John E. Paul. “Modeling for health care and other policy decisions: uses, roles, and validity.” Value Health 5, no. 1 (2002): 62–63.
    Link to Item
  - Smith, V. K., D. H. Taylor, F. A. Sloan, F. R. Johnson, and W. H. Desvousges. “Do smokers respond to health shocks?” Review of Economics and Statistics 83, no. 4 (November 1, 2001): 675–87. https://doi.org/10.1162/003465301753237759.
    Full Text Open Access Copy
  - Bingham, M. F., F. R. Johnson, and D. Miller. “Modeling choice behavior for new pharmaceutical products.” Value Health 4, no. 1 (2001): 32–44. https://doi.org/10.1046/j.1524-4733.2001.004001032.x.
    Full Text Link to Item
  - Johnson, F. R., R. W. Dunford, W. H. Desvousges, and M. R. Banzhaf. “Role of Knowledge in Assessing Nonuse Values for Natural Resource Damages.” Growth and Change 32, no. 1 (January 1, 2001): 43–68. https://doi.org/10.1111/0017-4815.00149.
    Full Text
  - Johnson, F. R., M. R. Banzhaf, and W. H. Desvousges. “Willingness to pay for improved respiratory and cardiovascular health: a multiple-format, stated-preference approach.” Health Econ 9, no. 4 (June 2000): 295–317. https://doi.org/10.1002/1099-1050(200006)9:4<295::aid-hec520>3.0.co;2-d.
    Full Text Link to Item
  - Train, K., D. McFadden, and R. Johnson. “Discussion of Morey and Waldman's 'measurement error in recreation demand models'.” Journal of Environmental Economics and Management 40, no. 1 (January 1, 2000): 76–81. https://doi.org/10.1006/jeem.1999.1084.
    Full Text
  - Gray, Darryl T., and Milton C. Weinstein. “Decision and Cost-Utility Analyses of Surgical versus Transcatheter Closure of Patent Ductus Arteriosus.” Medical Decision Making 18, no. 2 (January 1998): 187–201. https://doi.org/10.1177/0272989x9801800208.
    Full Text
  - Johnson, F. R., W. H. Desvousges, M. C. Ruby, D. Stieb, and P. De Civita. “Eliciting stated health preferences: an application to willingness to pay for longevity.” Med Decis Making 18, no. 2 Suppl (1998): S57–67. https://doi.org/10.1177/0272989X98018002S08.
    Full Text Link to Item
  - Johnson, F. R., E. E. Fries, and H. S. Banzhaf. “Valuing morbidity: an integration of the willingness-to-pay and health-status index literatures.” J Health Econ 16, no. 6 (December 1997): 641–65. https://doi.org/10.1016/s0167-6296(97)00012-x.
    Full Text Link to Item
  - Dunford, R. W., F. Reed Johnson, and E. S. West. “Whose losses count in natural resource damages?” Contemporary Economic Policy 15, no. 4 (January 1, 1997): 77–87. https://doi.org/10.1111/j.1465-7287.1997.tb00491.x.
    Full Text
  - Johnson, F. R., and W. H. Desvousges. “Estimating stated preferences with rated-pair data: Environmental, health, and employment effects of energy programs.” Journal of Environmental Economics and Management 34, no. 1 (January 1, 1997): 79–99. https://doi.org/10.1006/jeem.1997.1002.
    Full Text
  - Johnson, F. R., E. E. Fries, and H. S. Banzhaf. “An alternative approach to morbidity valuation: A meta analysis.” American Journal of Agricultural Economics 78, no. 5 (December 1, 1996): 1407–1407.
    Link to Item
  - Banzhaf, H. S., W. H. Desvousges, and F. R. Johnson. “Assessing the externalities of electricity generation in the Midwest.” Resource and Energy Economics 18, no. 4 (January 1, 1996): 395–421. https://doi.org/10.1016/S0928-7655(97)00042-0.
    Full Text
  - Boyle, K. J., F. R. Johnson, D. W. McCollum, W. H. Desvousges, R. W. Dunford, and S. P. Hudson. “Valuing public goods: Discrete versus continuous contingent-valuation responses.” Land Economics 72, no. 3 (January 1, 1996): 381–96. https://doi.org/10.2307/3147204.
    Full Text
  - Boyle, K. J., W. H. Desvousges, F. R. Johnson, R. W. Dunford, and S. P. Hudson. “An investigation of part-whole biases in contingent-valuation studies.” Journal of Environmental Economics and Management 27, no. 1 (January 1, 1994): 64–83. https://doi.org/10.1006/jeem.1994.1026.
    Full Text
  - Luken, R. A., F. R. Johnson, and V. Kibler. “Benefits and costs of pulp and paper effluent controls under the Clean Water Act.” Water Resources Research 28, no. 3 (January 1, 1992): 665–74. https://doi.org/10.1029/91WR02593.
    Full Text
  - Fisher, A., and F. R. Johnson. “Radon risk communication research: practical lessons.” J Air Waste Manage Assoc 40, no. 5 (May 1990): 738–39. https://doi.org/10.1080/10473289.1990.10466718.
    Full Text Link to Item
  - Smith, V. K., W. H. Desvousges, F. R. Johnson, and A. Fisher. “Can public information programs affect risk perceptions?” Journal of Policy Analysis and Management 9, no. 1 (January 1, 1990): 41–59. https://doi.org/10.2307/3325112.
    Full Text
  - Dinan, T., and F. R. Johnson. “Effects of hazardous waste risks on property transfers: legal liability vs. direct regulation.” Natural Resources Journal 30, no. 3 (January 1, 1990): 521–36.
  - Johnson, F. R., and A. Fisher. “Conventional Wisdom on Risk Communication and Evidence from a Field Experiment.” Risk Analysis 9, no. 2 (January 1, 1989): 209–13. https://doi.org/10.1111/j.1539-6924.1989.tb01241.x.
    Full Text
  - Johnson, F. R. “Economic costs of misinforming about risk: the EDB scare and the media.” Risk Anal 8, no. 2 (June 1988): 261–69. https://doi.org/10.1111/j.1539-6924.1988.tb01179.x.
    Full Text Link to Item
  - Smith, V. K., W. H. Desvousges, A. Fisher, and F. R. Johnson. “Learning about radon's risk.” Journal of Risk and Uncertainty 1, no. 2 (June 1, 1988): 233–58. https://doi.org/10.1007/BF00056169.
    Full Text
  - Johnson, F. R., A. Fisher, V. K. Smith, and W. H. Desvousges. “Informed choice or regulated risk?” Environment 30, no. 4 (January 1, 1988). https://doi.org/10.1080/00139157.1988.9928909.
    Full Text
  - Smith, V. K., and F. R. Johnson. “How do risk perceptions respond to information? The case of radon.” Review of Economics &Amp; Statistics 70, no. 1 (January 1, 1988): 1–8. https://doi.org/10.2307/1928144.
    Full Text
  - Johnson, F. R., and R. A. Luken. “Radon risk information and voluntary protection: evidence from a natural experiment.” Risk Anal 7, no. 1 (March 1987): 97–107. https://doi.org/10.1111/j.1539-6924.1987.tb00973.x.
    Full Text Link to Item
  - Haspel, A. E., and F. R. Johnson. “Substitutability, reversibility, and the development- conservation quandary.” Journal of Environmental Management 15, no. 1 (January 1, 1982): 79–91.
  - Haspel, A. E., and F. R. Johnson. “Multiple destination trip bias in recreation benefit estimation.” Land Economics 58, no. 3 (January 1, 1982): 364–72. https://doi.org/10.2307/3145943.
    Full Text
  - Cuddington, J. T., F. R. Johnson, and J. L. Knetsch. “Valuing amenity resources in the presence of substitutes.” Land Economics 57, no. 4 (January 1, 1981): 526–35. https://doi.org/10.2307/3145668.
    Full Text
  - Johnson, F. R. “Federal project evaluation and intangible resources. The Tellico Dam.” Resources Policy 7, no. 3 (January 1, 1981): 197–205. https://doi.org/10.1016/0301-4207(81)90005-2.
    Full Text
  - Johnson, F. R. “Income distributional effects of air pollution abatement: A general equilibrium approach.” Atlantic Economic Journal 8, no. 4 (December 1, 1980): 10–21. https://doi.org/10.1007/BF02300509.
    Full Text
  - Johnson, F. R. “Recreation benefit estimation in theory and practice: a comment on imperfect methods.” Journal of Forestry 78, no. 1 (January 1, 1980): 24–25.
  - Reed Johnson, F. “The mormon church as a central command system.” Review of Social Economy 37, no. 1 (January 1, 1979): 79–94. https://doi.org/10.1080/00346767900000006.
    Full Text
  - Kulin, Nathalie A., Deborah Marshall, F Reed Johnson, and Stephanie Van Bebber. “Conducting Surveys in the Era of Cellphones: Review of the Use of Online Panels in the Medical Literature,” n.d.
- Book Sections
  - Johnson, F. R., and M. Zhou. “Quantifying Patient Preferences for Regulatory Benefit–Risk Assessments.” In Benefit-Risk Assessment Methods in Medical Product Development: Bridging Qualitative and Quantitative Assessments, 85–104, 2017. https://doi.org/10.1201/b20302-5.
    Full Text
  - Johnson, F. R., A. B. Hauber, and J. Zhang. “Quantifying patient preferences to inform benefit-risk evaluations.” In Benefit-Risk Assessment in Pharmaceutical Research and Development, 37–58, 2013.
  - Reed Johnson, F., A. Fisher, V. Kerry Smith, and W. H. Desvousges. “Informed choice or regulated risk? Lessons from a study in radon risk communication.” In Readings in Risk, 247–60, 2013. https://doi.org/10.4324/9781315060590.
    Full Text
  - Johnson, F. R., A. B. Hauber, S. Ozdemir, C. A. Siegel, B. E. Sands, and S. Hass. “Quantitative benefit-risk tradeoff preferences for crohn's disease treatments - implications for regulatory decision making and disease management.” In Advances in Medicine and Biology, 17:235–45, 2011.
- Conference Papers
  - Gonzalez, Juan Marcos, Carolyn Hutyra, Shelby D. Reed, Reed Johnson, and Richard Mather. “CONSTRUCTING A SHOT-FORM DISCRETE-CHOICE EXPERIMENT: SUPPORTING SHARED DECISION-MAKING IN THE TREATMENT OF FIRST-TIME ANTERIOR SHOULDER DISLOCATION.” In Medical Decision Making, 41:E337–38, 2021.
    Link to Item
  - Johnson, F Reed, Juan Marcos Gonzalez, and Shelby Reed. “The Faster, the Better: QALY Distortions in Valuing Speed of Onset of Action.” In Patient Patient Centered Outcomes Research, 14:865–865, 2021.
    Link to Item
  - Reed, S., J. C. Yang, J. Gonzalez, and F. R. Johnson. “VALUING HOPE WITH CANCER TREATMENTS INDEPENDENT OF SURVIVAL GAINS.” In Value in Health, 24:S57–S57, 2021.
    Link to Item
  - Johnson, Reed, Angelyn Fairchild, Liping Huang, and Amit Srivastava. “UNDERSTANDING PATIENT PREFERENCES FOR MENINGOCOCCAL SEROGROUP B VACCINES.” In Journal of Adolescent Health, 66:S141–42. ELSEVIER SCIENCE INC, 2020.
    Link to Item
  - Hung, A., S. L. Hass, Gonzalez J. M. Sepulveda, J. C. Yang, S. Yu, S. Tilles, S. Donelson, E. Kim, and F. R. Johnson. “NOVEL PEANUT-ALLERGY DESENSITIZATION TREATMENTS: WHO IS LIKELY TO CHOOSE TREATMENT AND WHY.” In Value in Health, 23:S254–S254, 2020.
    Link to Item
  - Havrilesky, L. J., S. L. Lim, J. A. Ehrisman, A. Lorenzo, Alvarez A. Secord, J. C. Yang, F. R. Johnson, and S. D. Reed. “WOMEN'S PREFERENCES ON BENEFITS, RISKS, AND SIDE EFFECTS OF MAINTENANCE PARP INHIBITOR THERAPY IN OVARIAN CANCER.” In Value in Health, 22:S541–S541. ELSEVIER SCIENCE INC, 2019.
    Link to Item
  - Reed, S. D., A. O. Fairchild, F. R. Johnson, J. M. Gonzalez Sepulveda, R. J. Mentz, M. Krucoff, and S. Vemulapalli. “PATIENT PREFERENCES FOR MITRAL VALVE PROCEDURE-ASSOCIATED BENEFITS REVEAL GREATER RISK TOLERANCE AS HEART FAILURE SYMPTOMS WORSEN.” In Value in Health, 22:S567–S567. ELSEVIER SCIENCE INC, 2019.
    Link to Item
  - Johnson, F. R., J. M. Gonzalez, J. C. Yang, J. Weatherall, and S. Kymes. “An Embarrassment of Riches: What Can You Do with 10,000 Observations?” In Patient Patient Centered Outcomes Research, 12:434–434. ADIS INT LTD, 2019.
    Link to Item
  - Levitan, B. S., E. G. Katz, R. L. DiSantostefano, J. C. Yang, A. O. Fairchild, S. D. Reed, and F. R. Johnson. “Beating the Benchmarks: Using Patient Preferences to Increase the Probability of Development Success.” In Patient Patient Centered Outcomes Research, 12:431–431. ADIS INT LTD, 2019.
    Link to Item
  - Reed, Shelby D., Angelyn O. Fairchild, F. R. Johnson, Juan M. Gonzalez, Robert J. Mentz, Mitchell W. Krucoff, and Sreekanth Vemulapalli. “Patients Accept Mortality Risk for Improvements in Physical Functioning in Secondary Mitral Regurgitation.” In Journal of Cardiac Failure, 25:S149–S149. Elsevier BV, 2019. https://doi.org/10.1016/j.cardfail.2019.07.430.
    Full Text
  - Havrilesky, Laura Jean, Stephanie Lim, Jui-Chen Yang, Amelia Lorenzo, Jessie A. Ehrisman, Angeles Alvarez Secord, Reed Johnson, and Shelby D. Reed. “Patient preferences for maintenance PARP therapy in ovarian cancer treatment.” In Journal of Clinical Oncology, 37:5558–5558. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.15_suppl.5558.
    Full Text
  - Davidson, B. A., J. Ehrisman, S. D. Reed, J. Yang, F. R. Johnson, A. H. Buchanan, P. K. Marcom, and L. J. Havrilesky. “PMD180 - THE VALUE TO WOMEN WITH OVARIAN CANCER OF GENE VARIANTS WITH KNOWN AND UNKNOWN SIGNIFICANCE: A DISCRETE CHOICE EXPERIMENT.” In Value in Health, 21:S274–S274. Elsevier BV, 2018. https://doi.org/10.1016/j.jval.2018.09.1629.
    Full Text
  - DiSantostefano, Rachael, Shelby Reed, Jui-Chen Yang, Bennett Levitan, and F Reed Johnson. “Do people understand benefits and risks? Even ineffective treatments for delaying Alzheimer's disease are preferable to "doing nothing" for many older adults.” In Pharmacoepidemiology and Drug Safety, 27:511–511. WILEY, 2018.
    Link to Item
  - Campbell, Brittany, Jui-Chen Yang, Juan Gonzalez, Shelby Reed, Laura Havrilesky, F Reed Johnson, and Shelley Hwang. “Patient preferences for DCIS treatment strategies: A discrete-choice experiment.” In Annals of Surgical Oncology, 25:268–69. SPRINGER, 2018.
    Link to Item
  - Davidson, Brittany Anne, Jonathan Foote, Jessie Ehrisman, Jui-Chen Yang, Shelby D. Reed, Reed Johnson, Paula S. Lee, Angeles Alvarez Secord, Andrew Berchuck, and Laura Jean Havrilesky. “What factors drive the choice of a genetic test? A prospective study of the preferences of women with ovarian cancer.” In Journal of Clinical Oncology, 36:e13621–e13621. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.e13621.
    Full Text
  - Campbell, B. M., J. Yang, J. M. Gonzalez, S. D. Reed, L. Havrilesky, F. R. Johnson, and E. S. Hwang. “Patient Preferences for Health States Following Alternative Management Options for Ductal Carcinoma in Situ.” In Value in Health, 21:S11–12. Elsevier BV, 2018. https://doi.org/10.1016/j.jval.2018.04.056.
    Full Text
  - Johnson, F. R., R. Disantostefano, S. D. Reed, J. Yang, and B. Levitan. “Something is Better Than Nothing: The Value of Active Intervention on Stated Preferences for Treatments to Delay Onset of Alzheimer’s Disease Symptoms.” In Value in Health, 21:S208–S208. Elsevier BV, 2018. https://doi.org/10.1016/j.jval.2018.04.1425.
    Full Text
  - Gonzalez, J. M., F. R. Johnson, K. MacDonald, and D. Marshall. “EFFECTS ON COMPENSATING VARIATION OF NUMBER AND KIND OF COMPETING SUBSTITUTES IN DISCRETE-CHOICE EXPERIMENTS.” In Value in Health, 20:A196–A196. ELSEVIER SCIENCE INC, 2017.
    Link to Item
  - Marshall, D. A., J. M. Gonzalez, K. V. MacDonald, and F. R. Johnson. “Good Enough For Policy Work? Study-Design Challenges In Implementing Stated-Preference Methods For Complex Health-Care Technologies.” In Value in Health, 19:A481–A481. Elsevier BV, 2016. https://doi.org/10.1016/j.jval.2016.09.778.
    Full Text
  - Reed, S. D., J. Yang, R. Disantostefano, J. Streffer, B. Levitan, and F. R. Johnson. “Heterogeneous Preferences For Delaying Onset Of Alzheimer’s Disease Among Older Adults In The Us.” In Value in Health, 19:A352–A352. Elsevier BV, 2016. https://doi.org/10.1016/j.jval.2016.09.035.
    Full Text
  - Bewtra, Meenakshi, F Reed Johnson, Shelby Reed, Frank I. Scott, and James D. Lewis. “Everyone Isn't Average: Quantifying Heterogeneity in Crohn's Disease Patients' Benefit-Risk Tradeoff Preferences.” In Pharmacoepidemiology and Drug Safety, 25:10–10. WILEY-BLACKWELL, 2016.
    Link to Item
  - Fairchild, A. O., S. D. Reed, and F. R. Johnson. “TASTE HETEROGENEITY OR SOMETHING ELSE? ANALYZING STATED BENEFIT-RISK TRADEOFF PREFERENCES FOR PSORIASIS TREATMENTS.” In Value in Health, 19:A93–94. Elsevier BV, 2016. https://doi.org/10.1016/j.jval.2016.03.1741.
    Full Text
  - Buzaglo, Joanne, F Reed Johnson, Shelby Reed, Margaret Longacre, Mitch Golant, Melissa Miller, and Gwen Darien. “Understanding patient experiences to inform treatment decision-making: implications for the use of a patient-powered registry.” In Psycho Oncology, 24:21–21. WILEY-BLACKWELL, 2015.
    Link to Item
  - Hauber, A Brett, James T. Cross, David E. Yocum, F Reed Johnson, Jui-Chen Yang, Isidro Villaneuva, and Patricia P. Katz. “Rheumatologists' Benefit-Risk Preferences for Biologic Treatments for Rheumatoid Arthritis.” In Arthritis and Rheumatism, 63:S487–88. WILEY-BLACKWELL, 2011.
    Link to Item
  - Mohamed, A. F., B. Hauber, F. R. Johnson, and M. P. Neary. “PATIENT PREFERENCES FOR TARGETED AGENTS IN RENAL CELL CARCINOMA (RCC): A BENEFIT RISK CONJOINT STUDY.” In Annals of Oncology, 21:292–292. OXFORD UNIV PRESS, 2010.
    Link to Item
  - Coplan, Paul M., Brett A. Hauber, Ateesha Mohamed, Reed F. Johnson, and Bennett Levitan. “Patients' Value of Benefits and Harms of Migraine Treatments.” In Pharmacoepidemiology and Drug Safety, 19:S45–S45. WILEY-BLACKWELL, 2010.
    Link to Item
  - Hauber, A. B., M. E. Watson, A. F. Mohamed, F Reed Johnson, and J. E. Hernandez. “Differential willingness to accept adverse event (AE) risks among ART-naive HIV-positive African Americans (AA).” In Antiviral Therapy, 12:L45–L45. INT MEDICAL PRESS LTD, 2007.
    Link to Item
  - Gerber, R. A., A. B. Hauber, B. Bolinder, and F. R. Johnson. “Diabetes patients' stated preference for insulin therapies: trading health for convenience.” In Diabetologia, 47:A274–A274. SPRINGER, 2004.
    Link to Item
  - Hauber, A. B., F. R. Johnson, L. Sauriol, and B. Lescrauwaet. “Risking health to avoid injections: stated preferences of Canadians with diabetes.” In Diabetologia, 47:A276–A276. SPRINGER, 2004.
    Link to Item
  - Johnson, F. R., and K. E. Mathews. “Sources and effects of utility-theoretic inconsistency in stated-preference surveys.” In American Journal of Agricultural Economics, 83:1328–33, 2001. https://doi.org/10.1111/0002-9092.00286.
    Full Text
  - Mathews, K. E., W. H. Desvousges, F. R. Johnson, and M. C. Ruby. “Using economic models to inform restoration decisions: The Lavaca Bay, Texas experience.” In Restoration of Lost Human Uses of the Environment, edited by G. Cecil, 317–34. SETAC PRESS, 1999.
    Link to Item
  - Dunford, R. W., K. E. Mathews, and F. R. Johnson. “Conjoint analysis: A technique for determining compensatory restoration.” In 1997 International Oil Spill Conference, 1018–19. AMER PETROLEUM INST, 1997.
    Link to Item
  - Boyle, K. J., F. R. Johnson, and D. W. McCollum. “Anchoring and Adjustment in Single-Bounded, Contingent-Valuation Questions.” In American Journal of Agricultural Economics, 79:1495–1500, 1997. https://doi.org/10.2307/1244370.
    Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Previous Appointments & Affiliations

Academic Positions Outside Duke

Awards & Honors

Selected Grants

External Relationships

Selected Publications

Academic Articles

Book Sections

Conference Papers